A Study of Brenipatide in Adult Participants With Schizophrenia
Recruiting · Phase 2 · NCT07410507
Conditions: Schizophrenia
At a glance
- Research payments reported, 2025
- $14,806
- U.S. investigators named
- 8
- Sites paid
- 7
- Planned or actual enrollment
- 450
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- Brenipatide (drug), Placebo (drug)
- Dates
- Started 2026-02-10; completion 2027-11
- Results posted
- Not yet
The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of schizophrenia. The trial is divided into three periods as follows: Screening period will last approximately 1 month, treatment period will last a maximum of 12 months, and the follow up period will last approximately 2 months. The length of time of your study participation may last up to approximately 15 months.
From ClinicalTrials.gov, last updated 2026-10-07. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $14,806 in research payments for this study in 2025 (11 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Youngsun T. Cho, M.D./PH.D. Psychiatry · New Haven, CT
- Joseph P. Mcevoy, MD Psychiatry · Augusta, GA
- Abid K. Nazeer, M.D. Psychiatry · Oak Brook, IL
- Virginie-anne Chouinard, M.D. Psychiatry · Boston, MA
- Xiaoduo Fan, MD Psychiatry · Worcester, MA
- Junaid M. Syed, M.D. Psychiatry · Saint Louis, MO
- Mark J. Stillman, M.D. Neurology · Independence, OH
- Lili Meisamy, DO Psychiatry · Dallas, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- $4,368
- Re Cognition Health Corporation $2,921
- Univ of Massachusetts DBA Univ of Massachusetts $1,456
- Alexian Brothers Hospital Network $1,456
- Medical College of Georgia $1,456
- New Horizon Research Center $1,053
- Mclean Hospital Corporation, MA $1,053
- Yale University $1,044
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.